Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan David

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progressionZhe Jin, James P Hamilton, Jian Yang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 11, 2012
LARP7 is a potential tumor suppressor gene in gastric cancerYulan Cheng, Zhe Jin, Rachana Agarwal, et al.
Inflammatory Bowel Diseases|August 11, 2011
Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancersAlexandru V Olaru, Yulan Cheng, Rachana Agarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancerZhe Jin, Alexandru Olaru, Jian Yang, et al.
Gastroenterology|May 8, 2009
The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and BimTakatsugu Kan, Fumiaki Sato, Tetsuo Ito, et al.
International Journal of Cancer|August 30, 2008
Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factorsZhe Jin, Yulan Cheng, Alexandru Olaru, et al.
Inflammatory Bowel Diseases|September 18, 2010
Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformationAlexandru V Olaru, Florin M Selaru, Yuriko Mori, et al.
International Journal of Cancer|December 21, 2010
Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancerTetsuo Ito, Fumiaki Sato, Takatsugu Kan, et al.
Cancer Discovery|August 11, 2012
Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinomaNishant Agrawal, Yuchen Jiao, Chetan Bettegowda, et al.
BMJ Global Health|May 9, 2025
Characterising the effects of displacement on gender-based violence among women living with HIV in Ukraine: a cross-sectional studyAlthea Wolfe, Mary Anne Roach, Gnilane Turpin, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progressionZhe Jin, James P Hamilton, Jian Yang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 11, 2012
LARP7 is a potential tumor suppressor gene in gastric cancerYulan Cheng, Zhe Jin, Rachana Agarwal, et al.
Inflammatory Bowel Diseases|August 11, 2011
Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancersAlexandru V Olaru, Yulan Cheng, Rachana Agarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancerZhe Jin, Alexandru Olaru, Jian Yang, et al.
Gastroenterology|May 8, 2009
The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and BimTakatsugu Kan, Fumiaki Sato, Tetsuo Ito, et al.
International Journal of Cancer|August 30, 2008
Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factorsZhe Jin, Yulan Cheng, Alexandru Olaru, et al.
Inflammatory Bowel Diseases|September 18, 2010
Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformationAlexandru V Olaru, Florin M Selaru, Yuriko Mori, et al.
International Journal of Cancer|December 21, 2010
Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancerTetsuo Ito, Fumiaki Sato, Takatsugu Kan, et al.
Cancer Discovery|August 11, 2012
Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinomaNishant Agrawal, Yuchen Jiao, Chetan Bettegowda, et al.
BMJ Global Health|May 9, 2025
Characterising the effects of displacement on gender-based violence among women living with HIV in Ukraine: a cross-sectional studyAlthea Wolfe, Mary Anne Roach, Gnilane Turpin, et al.
Pageof 5